The Global Visual Arts Therapy Market Growth Accelerated By Rising Adoption Of Visual Arts Therapy In Tackling Mental Illness
Visual arts therapy involves engagement in artistic activities such as drawing, painting, sculpting, and other art forms to improve emotional, physical, and mental well-being. It helps patients express themselves creatively, enhance their cognition and motor functions, address trauma, reduce stress and anxiety. The global visual arts therapy market has witnessed immense growth owing to the increasing awareness about mental health issues and benefits of art in managing conditions like depression, trauma, and stress.
The global visual arts therapy Market is estimated to be valued at US$ 1.38 billion in 2023 and is expected to exhibit a CAGR of 3.9% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
According to WHO, 1 in 4 people suffer from mental disorders worldwide. Visual arts therapy has gained prominence in tackling issues like depression, PTSD, substance abuse, and stress. It provides non-verbal, creative means of expression and processing difficult emotions to patients. Growing acceptance of alternative therapies for mental wellness management is a major factor propelling the demand for visual arts therapy services. Various mental healthcare organizations and hospitals have incorporated it into their treatment programs owing to its effectiveness.
Segment Analysis
Visual Arts Therapy Market is segmented by type into art therapy, dance/movement therapy, drama therapy, music therapy, and poetry/writing therapy. Among these, art therapy dominates the market and accounts for the largest market share. It involves the use of art materials such as paints, crayons and modelling clay to express emotions and facilitate communication. Art therapists believe creative expression through visual art can help reduce anxiety and increase self-esteem.
Key Takeaways
The Global Visual Arts Therapy Market Size is expected to witness high growth over the forecast period of 2023 to 2030. The global visual arts therapy Market is estimated to be valued at US$ 1.38 billion in 2023 and is expected to exhibit a CAGR of 3.9% over the forecast period 2023-2030.
Regional analysis shows that North America currently dominates the market due to prevalence of mental health issues and favorable reimbursement policies. The region is expected to continue its dominance during the forecast period supported by growing awareness about creative arts therapies and their mental and physical benefits. Europe is the second largest market for visual arts therapy currently. Countries like the UK, Germany, France have universal healthcare coverage for mental illnesses further driving the adoption of creative arts therapies. Growing geriatric population suffering from Alzheimer's and dementia in European countries also contributes to market growth.
Key players operating in the visual arts therapy market are Mitsubishi Gas Chemical Company Inc., Takeda Pharmaceutical Company Limited, Pfizer Inc., Eli Lilly and Company, Allergan Plc., Johnson & Johnson, GlaxoSmithKline plc., Abbott Laboratories, Novartis AG, AstraZeneca plc., Otsuka Pharmaceutical Co., Ltd. and others. These players are focusing on expansion in emerging markets of Asia Pacific and Latin America through collaborations with local hospitals and clinics. Introduction of digital technologies is also expected to drive their revenue growth during the forecast period.
Get more insights on this topic:
https://www.marketwebjournal.com/visual-arts-therapy-market-market-size-share-analysis-growth/
Comments
0 comment